Vireo Growth (VREOF) Selling, General & Administrative (2020 - 2026)
Vireo Growth (VREOF) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 304.00 Mn |
| 3 | Zoetis | 32.53 Bn | 30.59 Bn | 1.62 Bn | 588.00 Mn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 5.21 Bn |
| 5 | United Therapeutics | 22.99 Bn | 20.84 Bn | 648.10 Mn | 184.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.42 Bn | 18.61 Bn | 1.16 Bn | 928.80 Mn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 318.50 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 381.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 30.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.80 Mn |
| Dec 31, 2025 | 31.58 Mn |
| Sep 30, 2025 | 29.68 Mn |
| Jun 30, 2025 | 12.45 Mn |
| Mar 31, 2025 | 7.40 Mn |
| Dec 31, 2024 | 6.54 Mn |
| Sep 30, 2024 | 6.91 Mn |
| Jun 30, 2024 | 7.56 Mn |
| Mar 31, 2024 | 7.05 Mn |
| Dec 31, 2023 | 6.25 Mn |
| Sep 30, 2023 | 6.75 Mn |
| Jun 30, 2023 | 8.06 Mn |
| Mar 31, 2023 | 7.16 Mn |
| Dec 31, 2022 | 7.43 Mn |
| Sep 30, 2022 | 8.49 Mn |
| Jun 30, 2022 | 8.63 Mn |
| Mar 31, 2022 | 9.28 Mn |
| Dec 31, 2021 | 9.21 Mn |
| Sep 30, 2021 | 8.11 Mn |
| Jun 30, 2021 | 8.30 Mn |